0000899243-18-014685.txt : 20180601
0000899243-18-014685.hdr.sgml : 20180601
20180601163030
ACCESSION NUMBER: 0000899243-18-014685
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180531
FILED AS OF DATE: 20180601
DATE AS OF CHANGE: 20180601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUEHL DANIEL W
CENTRAL INDEX KEY: 0001283569
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
FILM NUMBER: 18875460
MAIL ADDRESS:
STREET 1: 5 BILLERICA PARK
STREET 2: 101 BILLERICA AVE
CITY: NORTH BILLERCA
STATE: MA
ZIP: 01862
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-31
0
0001466301
Clovis Oncology, Inc.
CLVS
0001283569
MUEHL DANIEL W
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY, SUITE 100
BOULDER
CO
80301
0
1
0
0
See Remarks
Common Stock
2018-05-31
4
M
0
547
A
4500
D
Common Stock
2018-05-31
4
F
0
248
48.63
D
4252
D
Restricted Stock Units
2018-05-31
4
M
0
547
0.00
D
Common Stock
547
4921
D
Each Restricted Stock Unit represents the right to receive one share of Common Stock.
On August 25, 2016, the reporting person was granted 8,750 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
Senior Vice President of Finance, Principal Financial Officer and Principal Accounting Officer
/s/ Daniel W. Muehl
2018-06-01